News & Videos - ADAMIS PHARMACEUTICALS

Thinking about buying stock in Aravive, Oncolytics Biotech, Galecto, Adamis Pharmaceuticals, or Cambium Networks? PR Newswire NEW YORK, Aug. 3, 2023 NEW YORK , Aug. 3, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ARAV, ONCY, GLTO, ADMP, and CMBM. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ARAV:...

Thinking about buying stock in Tupperware Brands, Archer Aviation, Apellis Pharmaceuticals, Adamis Pharmaceuticals, or ABVC BioPharma? PR Newswire NEW YORK, Aug. 2, 2023 NEW YORK , Aug. 2, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TUP, ACHR, APLS, ADMP, and ABVC. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. TUP:...

Thinking about buying stock in MicroStrategy, Adamis Pharmaceuticals, Lulu's Fashion Lounge Holdings, Lucid Group, or Virgin Galactic? PR Newswire NEW YORK, June 26, 2023 NEW YORK , June 26, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MSTR, ADMP, LVLU, LCID, and SPCE. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. MSTR:...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Adamis Pharmaceuticals Corporation (the “Company”) (NasdaqCM: ADMP) with DMK Pharmaceuticals, Corp. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you would like to discuss your legal rights regarding the proposed sale, you may, without...

SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Adamis Pharmaceuticals Corp. - ADMP PR Newswire NEW YORK, March 1, 2023 NEW YORK , March 1, 2023 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City , is...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) and DMK Pharmaceuticals, Corp. is fair to Adamis shareholders. Halper Sadeh encourages Adamis shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected] . The investigation concerns whether Adamis and its board violated the federal...

Thinking about buying stock in Pluristem Therapeutics, DiDi Global, Robinhood Markets, Bitfarms, or Adamis Pharmaceuticals? PR Newswire NEW YORK, Jan. 10, 2022 NEW YORK , Jan. 10, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PSTI, DIDI, HOOD, BITF, and ADMP. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. PSTI:...

Thinking about buying stock in Progenity, Atea Pharmaceuticals, Peabody Energy, Adamis Pharmaceuticals, or Ion Geophysical? PR Newswire NEW YORK, Oct. 19, 2021 NEW YORK , Oct. 19, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PROG, AVIR, BTU, ADMP, and IO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. PROG:...

Thinking about buying stock in Ion Geophysical, Valneva SE, Adamis Pharmaceuticals, Oyster Point Pharma, or InMed Pharmaceuticals? PR Newswire NEW YORK, Oct. 18, 2021 NEW YORK , Oct. 18, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IO, VALN, ADMP, OYST, and INM. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. IO:...

Thinking about buying stock in Bio-Path Holdings, AzurRx BioPharma, Adamis Pharmaceuticals, indie Semiconductor, or Orphazyme? PR Newswire NEW YORK, Aug. 24, 2021 NEW YORK , Aug. 24, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BPTH, AZRX, ADMP, INDI, and ORPH. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. BPTH:...

Thinking about buying stock in MINISO Group, Adamis Pharmaceuticals, Sundial Growers, Palantir Technologies, or Zomedica? PR Newswire NEW YORK, Aug. 19, 2021 NEW YORK , Aug. 19, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MNSO, ADMP, SNDL, PLTR, and ZOM. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. MNSO:...

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis” or the “Company”) today announced that based on the Inspector of Election’s certified results from the Company’s 2021 Annual Meeting of Stockholders (the “Annual Meeting”), each of the Company’s nominees – Howard C. Birndorf, Roshawn A. Blunt, Dennis J. Carlo, Ph.D., David J. Marguglio and Richard C. Williams – have been re-elected to the Board of Directors (the "Board"). According to the Inspector of Election’s...

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis” or the “Company”) today urged its valued stockholders to vote to reelect all five members of the Company’s Board of Directors (the “Board”) at the upcoming Annual Meeting of Stockholders (the “Annual Meeting”) on July 16, 2021. In addition, the Board issued the following statement: “Ahead of this year’s Annual Meeting, the Board prioritized engaging with stockholders and gathering feedback regarding the Company’s...

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today issued the below letter to stockholders. *** July 1, 2021 Dear Stockholders, The Board of Directors (the "Board") appreciates your continued investment in Adamis Pharmaceuticals Corporation ("Adamis" or the "Company" or “we”). The Board also appreciates the feedback that many stockholders have provided in recent weeks. As we work to position Adamis for long-term success, please trust that this input will be carefully assessed and...

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today issued the below letter to stockholders. June 28, 2021 Dear Stockholder, The Board of Directors (the "Board") appreciates your continued investment in Adamis Pharmaceuticals Corporation ("Adamis" or the "Company"). Ahead of our Annual Meeting of Stockholders on July 16 th (the "Annual Meeting"), we want to once again urge you to vote to re-elect all five members of the Board. We believe maintaining continuity in the boardroom is critical as...

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission and sent the below letter to stockholders. The letter has been signed by all five members of the Company’s Board of Directors: Howard C. Birndorf, Roshawn Blunt, Dennis J. Carlo, Ph.D., David J. Marguglio and Richard C. Williams. *** June 14, 2021 Dear Stockholder, The Board of Directors (the "Board") thanks you for your continued...

...

...

...

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Adamis Pharmaceuticals Corporation (“Adamis” or the “Company”) (NASDAQ: ADMP ) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Adamis investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws,...